Activity of combined androgen receptor antagonism and cell cycle inhibition in androgen receptor-positive triple-negative breast cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype, with a peak recurrence rate within the first few years post diagnosis. Few targeted therapies are available to treat this breast cancer (BC) subtype, defined by the lack of estrogen and progesterone receptors (ER and PR) and without ampl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Cancer Ther
Autori principali: Christenson, Jessica L., O’Neill, Kathleen I., Williams, Michelle M., Spoelstra, Nicole S., Jones, Kenneth L., Trahan, G. Devon, Reese, Jordan, Van Patten, Elaina T, Elias, Anthony, Eisner, Joel R., Richer, Jennifer K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8172456/
https://ncbi.nlm.nih.gov/pubmed/33722849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-20-0807
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi